Form 8-K - Current report:
SEC Accession No. 0001390478-14-000061
Filing Date
2014-11-03
Accepted
2014-11-03 16:32:49
Documents
3
Period of Report
2014-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gale-201409308xk.htm 8-K 39834
2 EXHIBIT gale-20140930ex991.htm EX-99.1 137040
3 GRAPHIC earningsreleasegraphic.jpg GRAPHIC 102112
  Complete submission text file 0001390478-14-000061.txt   319172
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 141189873
SIC: 2834 Pharmaceutical Preparations